Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for erectile dysfunction: where is it going?

George J Christ1

  • 1Department of Urology, Institute for Smooth Muscle Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. christ@aecom.yu.edu

Current Opinion in Urology
|November 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repairing Volumetric Muscle Loss with Skeletal Muscle Units and Hyaluronic Acid Hydrogel in Rats.

Tissue engineering. Part A·2025
Same author

Freeze-Dried Porous Collagen Scaffolds for the Repair of Volumetric Muscle Loss Injuries.

ACS biomaterials science & engineering·2025
Same author

In Vivo Functional Assessment of Rat Masseter Muscle Following Surgical Creation of a Volumetric Muscle Loss (VML) Injury.

Journal of visualized experiments : JoVE·2024
Same author

Freeze-dried porous collagen scaffolds for the repair of volumetric muscle loss injuries.

bioRxiv : the preprint server for biology·2024
Same author

Optimized Biomanufacturing for Treatment of Volumetric Muscle Loss Enables Physiomimetic Recovery.

Tissue engineering. Part A·2024
Same author

Comprehensive dynamic and kinematic analysis of the rodent hindlimb during over ground walking.

Scientific reports·2022

Gene therapy shows preclinical promise for treating erectile dysfunction. Future research will focus on optimizing safety, specificity, and longevity of gene transfer strategies for clinical success.

Area of Science:

  • Regenerative Medicine
  • Molecular Biology
  • Urology

Background:

  • Erectile dysfunction (ED) is a prevalent condition with significant impact on quality of life.
  • Current treatments for ED have limitations, driving the need for novel therapeutic approaches.
  • Gene therapy offers a promising avenue for addressing the underlying molecular mechanisms of ED.

Purpose of the Study:

  • To review recent preclinical data on gene therapy for erectile dysfunction from leading US laboratories.
  • To discuss the implications of these findings for gene therapy in general and for non-life-threatening disorders.
  • To outline potential gene-based treatment strategies for erectile dysfunction.

Main Methods:

  • Review of preclinical research data from multiple US laboratories.

Related Experiment Videos

  • Analysis of various gene therapy vectors and molecular targets employed.
  • Synthesis of findings to establish proof-of-concept for gene therapy in ED treatment.

    • Main Results:

    • Preclinical studies demonstrate successful proof-of-concept for gene therapy in treating erectile dysfunction.
    • Diverse vectors and molecular targets have been effectively utilized in preclinical models.
    • Multiple gene-based strategies show potential for future erectile dysfunction treatments.

    Conclusions:

    • Preclinical success of gene therapy for ED aligns with the complex regulatory mechanisms of erections.
    • The primary challenge for clinical translation lies in ensuring safety, specificity, and longevity of gene therapy vectors.
    • Identifying gene therapy strategies with optimal safety profiles and on-demand efficacy is the next critical hurdle for treating erectile dysfunction.